Bradley Foster & Sargent Inc Quest Diagnostics Inc Transaction History

Bradley Foster & Sargent Inc

$5.82 Billion
Q3 2024

A detailed history of Bradley Foster & Sargent Inc transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Bradley Foster & Sargent Inc holds 1,548 shares of DGX stock, worth $212,215. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,548

Previous 1,548 -0.0%

Holding current value

$212,215

Previous $211,000 0.47%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$123.78 - $142.11 $12,378 - $14,211	-100 Reduced 6.07%	1,548 $206,000
Q1 2023 May 08, 2023	SELL	$131.53 - $155.76 $263 - $311	-2 Reduced 0.12%	1,648 $233,000
Q1 2022 May 16, 2022	SELL	$129.09 - $164.35 $12,909 - $16,435	-100 Reduced 5.71%	1,650 $226,000
Q3 2021 Nov 10, 2021	BUY	$132.95 - $158.0 $265 - $316	2 Added 0.11%	1,750 $254,000
Q4 2020 Feb 11, 2021	SELL	$112.7 - $128.05 $92,526 - $105,129	-821 Reduced 31.96%	1,748 $208,000
Q3 2020 Oct 26, 2020	SELL	$107.05 - $130.01 $101,697 - $123,509	-950 Reduced 27.0%	2,569 $294,000
Q1 2020 May 07, 2020	SELL	$75.14 - $115.68 $37,570 - $57,840	-500 Reduced 12.44%	3,519 $283,000
Q4 2019 Jan 29, 2020	BUY	$100.29 - $107.99 $115,132 - $123,972	1,148 Added 39.99%	4,019 $429,000
Q3 2019 Oct 30, 2019	BUY	$97.85 - $107.42 $22,407 - $24,599	229 Added 8.67%	2,871 $307,000
Q2 2019 Aug 08, 2019	SELL	$85.18 - $101.94 $21,295 - $25,485	-250 Reduced 8.64%	2,642 $269,000
Q3 2018 Oct 31, 2018	SELL	$105.42 - $114.99 $59,562 - $64,969	-565 Reduced 16.34%	2,892 $312,000
Q2 2018 Jul 31, 2018	BUY	$97.35 - $113.14 $6,327 - $7,354	65 Added 1.92%	3,457 $380,000
Q3 2017 Nov 03, 2017	BUY	$91.96 - $108.35 $311,928 - $367,523	3,392	3,392 $318,000

Others Institutions Holding DGX

# of Institutions

924

Shares Held

95.1M

Call Options Held

361K

Put Options Held

346K

View Full List

About QUEST DIAGNOSTICS INC

Ticker DGX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 113,887,000
Market Cap $15.6B
Description
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...

More about DGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bradley Foster & Sargent Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bradley Foster & Sargent Inc with notifications on news.

Account

Bradley Foster & Sargent Inc Quest Diagnostics Inc Transaction History